Recent evidence has supported a pathogenic role for neuroinflammation in Parkinson's
disease (PD). Inflammatory response has been associated with symptoms and subtypes of …

Recent evidence has supported a pathogenic role for neuroinflammation in Parkinson's
disease (PD). However, it is unclear whether the immune changes are involved in the initial …

Background Neuroprotective strategies are becoming relevant to slow down dopaminergic
cell death and inflammatory processes related to the progressive neurodegeneration in …

Inflammation has been linked to the development of nonmotor symptoms in Parkinson's
disease (PD), which greatly impact patients' quality of life and can often precede motor …

The motor symptoms of Parkinsons disease (PD) are due to the progressive degeneration of
dopaminergic neurons in the substantia nigra. Multiple neuroinflammatory processes are …

Parkinson's disease (PD) is a slowly progressive neurodegenerative disorder characterized
by the loss of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), striatal …

Animal models of Parkinson's disease (PD), a chronic and progressive neurodegenerative
disease of the central nervous system (CNS), play a key role in investigating the …

The current investigation compared intranigral lipopolysaccharide (LPS), 1-methyl-4-phenyl-
1, 2, 3, 6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA) administrations, in …

Inflammatory processes described in Parkinson's disease (PD) and its animal models
appear to be important in the progression of the pathogenesis, or even a triggering factor …

Neuroinflammation may play a role in the pathogenesis of Parkinson's disease (PD). The
present study questioned whether this neuroinflammatory response differs between the …